Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Statistics

Total Valuation

QNCX has a market cap or net worth of $70.48 million. The enterprise value is $54.63 million.

Market Cap	70.48M
Enterprise Value	54.63M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

QNCX has 45.47 million shares outstanding. The number of shares has increased by 11.45% in one year.

Current Share Class	45.47M
Shares Outstanding	45.47M
Shares Change (YoY)	+11.45%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	13.08%
Owned by Institutions (%)	15.58%
Float	36.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.68
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.85.

Current Ratio	4.05
Quick Ratio	3.89
Debt / Equity	0.85
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -130.90% and return on invested capital (ROIC) is -38.67%.

Return on Equity (ROE)	-130.90%
Return on Assets (ROA)	-17.80%
Return on Invested Capital (ROIC)	-38.67%
Return on Capital Employed (ROCE)	-38.42%
Revenue Per Employee	n/a
Profits Per Employee	-$1.69M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, QNCX has paid $103,000 in taxes.

Income Tax	103,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +120.96% in the last 52 weeks. The beta is 0.80, so QNCX's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+120.96%
50-Day Moving Average	1.14
200-Day Moving Average	1.34
Relative Strength Index (RSI)	67.40
Average Volume (20 Days)	311,809

Short Selling Information

The latest short interest is 473,979, so 1.04% of the outstanding shares have been sold short.

Short Interest	473,979
Short Previous Month	506,936
Short % of Shares Out	1.04%
Short % of Float	1.30%
Short Ratio (days to cover)	1.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-37.93M
Pretax Income	-30.20M
Net Income	-60.71M
EBITDA	-37.75M
EBIT	-37.93M
Earnings Per Share (EPS)	-$1.40

Balance Sheet

The company has $31.60 million in cash and $15.75 million in debt, giving a net cash position of $15.85 million or $0.35 per share.

Cash & Cash Equivalents	31.60M
Total Debt	15.75M
Net Cash	15.85M
Net Cash Per Share	$0.35
Equity (Book Value)	18.58M
Book Value Per Share	0.42
Working Capital	25.47M

Cash Flow

In the last 12 months, operating cash flow was -$33.15 million and capital expenditures -$366,000, giving a free cash flow of -$33.52 million.

Operating Cash Flow	-33.15M
Capital Expenditures	-366,000
Free Cash Flow	-33.52M
FCF Per Share	-$0.74

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNCX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.45%
Shareholder Yield	-11.45%
Earnings Yield	-86.14%
FCF Yield	-47.56%

Analyst Forecast

The average price target for QNCX is $8.00, which is 416.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	416.13%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1